Conditions: Moderate to Severe Palmar Plantar Psoriasis
Keywords: Palmar Plantar Psoriasis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 26
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the short and long term safety and effectiveness of ustekinumab in subjects with moderate to severe chronic palmar plantar psoriasis.

Detailed description:

Arms:

Interventions: intervention 1: Ustekinumab
Intervention descriptions: intervention 1: Dosing will consist of a 45mg subcutaneous injection for patients weighing less than 100 kg and a 90 mg subcutaneous injection for patients whose weight is greater than 100 kg. Dosing will begin on week 0 followed by subsequent dosing on week 4 and week 16.

Protocol document: